For research use only. Not for therapeutic Use.
Lanoconazole(Cat No.:R006491)is an antifungal agent used primarily for treating superficial fungal infections, such as dermatophytes and yeast. It functions by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, disrupting cell integrity and growth. Lanoconazole demonstrates broad-spectrum activity against various fungal species, including Trichophyton, Epidermophyton, and Microsporum. It is typically administered topically in the form of creams or solutions. Its high efficacy and minimal systemic absorption make it a valuable treatment for localized skin infections, offering a well-tolerated therapeutic option in dermatology.
Catalog Number | R006491 |
CAS Number | 101530-10-3 |
Synonyms | (E)-(+/-)-α-[4-(2-Chlorophenyl)-1,3-dithiolan-2-ylidene]-1H-imidazole-1-acetonitrile; Latoconazole; TJN-318; NND-318; Astat; |
Molecular Formula | C14H10ClN3S2 |
Purity | ≥95% |
Target | Fungal |
Storage | 3 years -20C powder |
IUPAC Name | (2E)-2-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile |
InChI | InChI=1S/C14H10ClN3S2/c15-11-4-2-1-3-10(11)13-8-19-14(20-13)12(7-16)18-6-5-17-9-18/h1-6,9,13H,8H2/b14-12+ |
InChIKey | ZRTQSJFIDWNVJW-WYMLVPIESA-N |
SMILES | C1C(S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=CC=CC=C3Cl |